355 related articles for article (PubMed ID: 30405600)
1. An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients.
Bassolas-Molina H; Raymond E; Labadia M; Wahle J; Ferrer-Picón E; Panzenbeck M; Zheng J; Harcken C; Hughes R; Turner M; Smith D; Calderón-Gómez E; Esteller M; Carrasco A; Esteve M; Dotti I; Corraliza AM; Masamunt MC; Arajol C; Guardiola J; Ricart E; Nabozny G; Salas A
Front Immunol; 2018; 9():2307. PubMed ID: 30405600
[No Abstract] [Full Text] [Related]
2. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
4. Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile.
Calderón-Gómez E; Bassolas-Molina H; Mora-Buch R; Dotti I; Planell N; Esteller M; Gallego M; Martí M; Garcia-Martín C; Martínez-Torró C; Ordás I; Singh S; Panés J; Benítez-Ribas D; Salas A
Gastroenterology; 2016 Sep; 151(3):489-500.e3. PubMed ID: 27267052
[TBL] [Abstract][Full Text] [Related]
5. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
6. Role of the IL23/IL17 Pathway in Crohn's Disease.
Schmitt H; Neurath MF; Atreya R
Front Immunol; 2021; 12():622934. PubMed ID: 33859636
[TBL] [Abstract][Full Text] [Related]
7. Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses.
Ecoeur F; Weiss J; Kaupmann K; Hintermann S; Orain D; Guntermann C
Front Immunol; 2019; 10():577. PubMed ID: 30972071
[TBL] [Abstract][Full Text] [Related]
8. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
9. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
[TBL] [Abstract][Full Text] [Related]
11. SIRT3 Activator Honokiol Inhibits Th17 Cell Differentiation and Alleviates Colitis.
Chen X; Zhang M; Zhou F; Gu Z; Li Y; Yu T; Peng C; Zhou L; Li X; Zhu D; Zhang X; Yu C
Inflamm Bowel Dis; 2023 Dec; 29(12):1929-1940. PubMed ID: 37335900
[TBL] [Abstract][Full Text] [Related]
12. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
[TBL] [Abstract][Full Text] [Related]
13. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
15. Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ Dependent.
Nizzoli G; Burrello C; Cribiù FM; Lovati G; Ercoli G; Botti F; Trombetta E; Porretti L; Todoerti K; Neri A; Giuffrè MR; Geginat J; Vecchi M; Rescigno M; Paroni M; Caprioli F; Facciotti F
J Crohns Colitis; 2018 Jul; 12(8):981-992. PubMed ID: 29697763
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease.
Igaki K; Nakamura Y; Tanaka M; Mizuno S; Yoshimatsu Y; Komoike Y; Uga K; Shibata A; Imaichi H; Takayuki S; Ishimura Y; Yamasaki M; Kanai T; Tsukimi Y; Tsuchimori N
Inflamm Res; 2019 Jun; 68(6):493-509. PubMed ID: 30972425
[TBL] [Abstract][Full Text] [Related]
18. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
Front Immunol; 2018; 9():1125. PubMed ID: 29910803
[TBL] [Abstract][Full Text] [Related]
19. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
